Register for OBR daily


IMS_White_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GALT $11.61 1.3300 +12.94%
PVCT $2.32 0.2100 +9.95%
SRNE $10.55 0.9000 +9.33%
AMBI $6.94 0.5300 +8.27%
CYTR $3.23 0.2300 +7.67%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

INO $2.52 -0.1500 -5.62%
THLD $3.83 -0.1900 -4.73%
INFI $10.15 -0.4500 -4.25%
NYMX $5.04 -0.2199 -4.18%
KPTI $31.09 -1.3100 -4.04%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

To Kill a Tumor: UF Physicians Target the Genes of Lung, Colon Cancers

(University of Florida, Gainesville) Apr 15, 2014 - University of Florida physicians and researchers are collaborating to map the genes of different types of cancer, and then deliver medication to attack cancer at its source.
read article 



Stiffness: A New Piece of the Breast Cancer Puzzle

(U of T News/University of Toronto [Toronto, Canada]) Apr 15, 2014 - A new study has linked the stiffness of breast tissue to the progression of a particularly aggressive form of breast cancer.
read article 



Sleep Apnea Linked to Cancer

(MedPage Today) Apr 15, 2014 - Cancer may be yet another risk to add to the list linked to obstructive sleep apnea (OSA), a longitudinal population-based study affirmed.
read article (free registration required) 



Shared Decision Making During Radiation Therapy Improves Patient Satisfaction, May Help Alleviate Anxiety, Depression

(Penn Medicine) Apr 15, 2014 - Playing an active role in their radiation treatment decisions leaves cancer patients feeling more satisfied with their care, and may even relieve psychological distress around the experience, researchers report in the journal Cancer.
read press release 



Oncologist Compensation Increases Slightly, Middle of Pack

(Medscape Medical News) Apr 16, 2014 - The annual Medscape Physician Compensation report is out once again. And it is a realistic, hype-free portrait of oncologist income.
read article (free registration required) 



DNA Alternative to Pap Smear Sparks Medical Debate

(ABC News/Associated Press) Apr 15, 2014 - A high-tech screening tool for cervical cancer is facing pushback from more than a dozen American patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: the Pap smear.
read article 



BioAlliance to Merge With Topotarget in All-Stock Deal

(Bloomberg) Apr 16, 2014 - BioAlliance Pharma SA plans to merge with Topotarget A/S of Denmark in an all-stock deal set to create a larger developer of treatments for rare cancers.
read article 



Nothing to Sneeze At: Merck Hay Fever Drug Approved

(Philadelphia Business Journal/HealthCare Inc. blog) Apr 15, 2014 - The Food and Drug Administration has granted marketing approval for Grastek, a drug developed by Merck & Co. Inc. to treat people with grass allergies.
read article 



BlackBerry Joins Soon-Shiong in Health-Care Venture

(Bloomberg) Apr 15, 2014 - BlackBerry Ltd., seeking to cut dependence on its declining phone unit, will invest in a health-care technology firm run by billionaire Patrick Soon-Shiong.
read article 



Congressional Report Urges FDA to Regulate e-Cigarette Marketing

(CBS News/Associated Press) Apr 15, 2014 - A new Congressional report released Monday sounds the alarm on marketing of electronic cigarettes, especially efforts made by companies to sell their products to young people.
read article 



FDA Approves GSK's Tanzeum to Treat Type 2 Diabetes

(Reuters) Apr 15, 2014 - The U.S. Food and Drug Administration approved GlaxoSmithKline Plc's Tanzeum injection for treating adults with type 2 diabetes, in combination with diet and exercise.
read article 



More U.S. Consumers Are Seeking Medical Care, Report Shows

(Los Angeles Times) Apr 15, 2014 - Suggesting a lengthy slowdown in healthcare spending could be over, Americans show higher demand for specialists, and other services.
read article (free registration required) 



Prices Soaring for Specialty Drugs, Researchers Find

(New York Times) Apr 15, 2014 - A report to be released on Tuesday by a major drug research firm says that even as prescription costs have plummeted, a small slice of the population with serious illnesses is being asked to shoulder more of the cost of expensive treatments.
read article 



Essay: A Radiation Reality Check

(Wall Street Journal) Apr 11, 2014 - From bananas to bricks, radioactivity is everywhere—but it's nothing to be afraid of.
read article (paid subscription required) 



MolecularHealth Launches Blog on the News, Trends and Technologies Shaping the Targeted Treatment of Cancer

(Yahoo! Finance) Apr 15, 2014 - The Targeting Cancer blog keeps oncologists, pathologists, patients and payers up-to-date on new developments in cancer treatment that promise a revolution in cancer care
read article 



Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. as Head of R&D and Chief Medical Officer

(Tokai Pharmaceuticals) Apr 15, 2014 - Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven diseases, today announced the appointment of Karen J. Ferrante, M.D. as head of R&D and chief medical officer.
read corporate press release 



Ohio State Hematologist Recognized Nationally With Top 10 Clinical Research Achievement Award

(OSUCCC - James) Apr 9, 2014 - John C. Byrd, MD, has again received national scientific recognition for his translational research investigating use of the drug, ibrutinib, in the treatment of chronic lymphocytic leukemia (CLL), at the 2014 Clinical Research Forum’s third annual Top 10 Research Achievement Awards.
read press release 



Pope Foundation Gives $1.3M to Cancer Research at UNC-Chapel Hill

(The News & Observer [Raleigh, NC]) Apr 14, 2014 - The John William Pope Foundation has made a $1.3 million gift to UNC-Chapel Hill for cancer research and treatment.
read article 



Cardio-Oncology Clinic Established at The Mount Sinai Hospital

(Mount Sinai Hospital) Apr 15, 2014 - Cardiologists and cancer experts at The Mount Sinai Hospital have joined forces to establish its first Cardio-Oncology Clinic at The Tisch Cancer Institute at The Mount Sinai Hospital.
read press release 



Cancer Center Agrees to $2.9M Settlement in Whistleblower Case

(Kansas City Business Journal) Apr 14, 2014 - Hope Cancer Institute Inc. and owner Dr. Raj Sadasivan have agreed to pay $2.9 million to the U.S. government to settle claims that the organization defrauded federal health care programs.
read article 



High-risk PCa: Urological or Radiation Oncological Approach

(EAU) Apr 15, 2014 - In the multidisciplinary Thematic Session 18, the urological and radiation oncological approaches to high-risk prostate cancer were discussed.
read article 



Plenary Session 5: Update and Controversies in Prostate Cancer

(EAU) Apr 15, 2014 - The last Plenary Session of this year’s event dealt with all aspects of prostate cancer, from genomic alterations to risk stratification.
read article 



Eventus Diagnostics Completes $2.72 Million Financing To Support Commercialization Of Its Octava™ Blood Tests For Breast Cancer Detection

(DigitalJournal.com) Apr 15, 2014 - Eventus Diagnostics, Inc. announced completion of a $2.72 million financing, the proceeds of which will mostly be used to support the continued development and commercialization of the company's Octava™ breast cancer tests.
read article 



Roche’s Breast-Cancer Drug Sales Surge, Led by Perjeta

(Bloomberg) Apr 15, 2014 - Roche Holding AG’s sales of breast-cancer medicines grew 17 percent in the first quarter as new drugs beat analysts’ estimates, eclipsing a decline in overall revenue.
read article 



AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) for Patients with Non-Small Cell Lung Cancer

(Yahoo! Finance) Apr 15, 2014 - Trial will evaluate investigational compound's efficacy and safety as an addition to standard chemotherapy in previously-untreated patients.
read article